Back to Results

Heartbeam Inc (BEAT)

Heartbeam Inc (BEAT) is a NASDAQ-listed common stock in the healthcare sector, classified as Healthcare Equipment & Supplies. As a common equity security, it represents ownership in Heartbeam Inc, a company associated with medical technology for cardiac assessment and monitoring. The business is linked to ECG-focused tools and software designed to capture and review heart activity data outside a traditional clinical setting. This listing should be understood as an operating company’s common stock rather than a fund, debt instrument, or other special security. The NASDAQ-BEAT ticker and common stock classification identify the instrument traded on the exchange.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-BEAT
$0.52
27.9% Upside
Undervalued
$3.17
685.8% Upside
Bargain
Weak
0.0%
November 5, 2026
2.8x
22.703 M
13.987 M
0.0%
84.3%
-11.3
69.0%
Valuation • Fair Value

Heartbeam Inc (NASDAQ-BEAT) Fair Value by Valuation Model

Review the available estimates for Heartbeam Inc (NASDAQ-BEAT), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.52

Estimated upside of 27.9% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.63

Discounted cash flow valuation reference.

Comps Fair Value

$0.49

Comparable-company valuation reference.

Analyst Price Target

$3.17

Analysts imply upside of 685.8%.

How to read these valuation models

Use the 5 available valuation references for Heartbeam Inc (NASDAQ-BEAT) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Heartbeam Inc (NASDAQ-BEAT)

Review the profitability and growth indicators currently supported by the latest data.

Revenue Forecast

370 K

Forward revenue estimate.

EBITDA

-20.303 M

Current operating profitability reference.

EBITDA Forecast

-26.5 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Heartbeam Inc (NASDAQ-BEAT) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Heartbeam Inc (NASDAQ-BEAT)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

3

Weak quality score that deserves closer review.

Altman Z-Score

-11.3

Lower score that deserves closer risk review.

FCF / Net Income

69.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Heartbeam Inc (NASDAQ-BEAT). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Heartbeam Inc (NASDAQ-BEAT)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 5, 2026

Days to Earnings

48

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Heartbeam Inc (NASDAQ-BEAT), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Heartbeam Inc (NASDAQ-BEAT) Stock Forecast & Technical Outlook

Review Heartbeam Inc (NASDAQ-BEAT) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Heartbeam Inc (NASDAQ-BEAT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Heartbeam Inc (NASDAQ-BEAT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Heartbeam Inc (NASDAQ-BEAT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Heartbeam Inc (NASDAQ-BEAT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Heartbeam Inc (NASDAQ-BEAT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Heartbeam Inc (NASDAQ-BEAT)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Heartbeam Inc (NASDAQ-BEAT) has a Strong Buy consensus, with 2 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 0
Sell 0
FAQ • Fast Investor Answers

Heartbeam Inc (NASDAQ-BEAT) Stock FAQ

Data-supported answers about Heartbeam Inc (NASDAQ-BEAT), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.52
Estimated upside 27.9%
Valuation Rating
Undervalued
Estimated upside of 27.9%
Analyst Target
$3.17
Implied upside 685.8%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Heartbeam Inc (NASDAQ-BEAT) is $0.52. This implies an estimated upside of 27.9% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 27.9% versus the current market price.

The available analyst price target for Heartbeam Inc (NASDAQ-BEAT) is $3.17. The analyst target implies estimated upside of 685.8%.

The current financial health read for Heartbeam Inc (NASDAQ-BEAT) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Heartbeam Inc (NASDAQ-BEAT) is November 5, 2026.

The latest available data indicates no current dividend yield for Heartbeam Inc (NASDAQ-BEAT).

The current market capitalization listed for Heartbeam Inc is 22.703 M.

The current enterprise value listed for Heartbeam Inc is 13.987 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Heartbeam Inc is NASDAQ-BEAT, and the stock is listed on NASDAQ.

Heartbeam Inc (NASDAQ-BEAT) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Heartbeam Inc is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Heartbeam Inc is 84.3%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 177.6 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 139 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 117.8 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 105.5 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 62.81 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 50.873 B
BDX NYSE Becton Dickinson and Co Fair Value Undervalued Market Cap 49.286 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 41.807 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 40.289 B
DXCM NASDAQ DexCom Inc Fair Value Fair Market Cap 33.717 B
RMD NYSE ResMed Inc Fair Value Undervalued Market Cap 32.188 B
ALC NYSE Alcon AG Fair Value Undervalued Market Cap 31.559 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Undervalued Market Cap 28.967 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Undervalued Market Cap 24.25 B
STE NYSE STERIS plc Fair Value Undervalued Market Cap 19.991 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Undervalued Market Cap 18.189 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 15.123 B
PEN NYSE Penumbra Inc Fair Value Fair Market Cap 12.51 B
BAX NYSE Baxter International Inc Fair Value Undervalued Market Cap 11.788 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 11.577 B